| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from OFIX graph: Code of Ethics ("AdvaMed Code") and the MedTech Europe Code of Ethical Business Practice ("MedTech Code"). Under the O… |
| JNJ |
Johnson & Johnson |
72%
|
Code of Ethics ("AdvaMed Code") and the MedTech Europe Code of Ethical Business Practice ("MedTech Code"). Under the Orthofix Academy program, we organize regular multilingual teaching seminars in 23… |
| ORANY |
ORANY |
72%
|
Reciprocal relationship from ORANY graph: Reciprocal relationship from OFIX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from OFIX graph: one facility in Irvine, Californi… |
| ORANY |
ORANY |
72%
|
one facility in Irvine, California, and any damage to that facility could adversely affect our ability to timely satisfy demand for those products. Out of an abundance of caution, in October 2020 we … |
| BIOLOGICS-TECHNOLOGIES |
BIOLOGICS-TECHNOLOGIES |
62%
|
outstanding immediately prior to the closing of the Merger was converted into 0.4163 shares of Orthofix common stock. The shares of common stock of Orthofix, as the corporate parent entity in the com… |
| BONE-GROWTH-THERAPIES-SPINAL-IMPLANTS-ENABLING-T |
BONE-GROWTH-THERAPIES-SPINAL-IMPLANTS-ENABLING-T |
62%
|
ated fees for purchasing such components or raw materials. These agreements outline the rights of each party with respect to quality assurance, inspection, and compliance with applicable law and cont… |
| ENABLING-TECHNOLOGIES |
ENABLING-TECHNOLOGIES |
62%
|
imizing osteoinductive content while providing an improved conductive matrix. Multiple compositions include 100% fibers, fibers with ABM, and fibers mixed with cancellous bone. Provided in both putty… |
| ENABLING-TECHNOLOGIES-WITHIN-ENABLING-TECHNOLOGI |
ENABLING-TECHNOLOGIES-WITHIN-ENABLING-TECHNOLOGI |
62%
|
outstanding immediately prior to the closing of the Merger was converted into 0.4163 shares of Orthofix common stock. The shares of common stock of Orthofix, as the corporate parent entity in the com… |
| HEALTH-CARE-INC |
HEALTH-CARE-INC |
62%
|
ements described above, see Item 1A of this Annual Report under the heading "Risk Factors." Accreditation Requirements Our subsidiary, Orthofix US LLC, has been accredited by the Accreditation Commis… |
| HSBC-VENTURES-USA-INC |
HSBC-VENTURES-USA-INC |
62%
|
urement 1.9 9.2 Operating loss (7.3 ) (25.2 ) Net loss (10.6 ) (27.4 ) 22 Net Sales by Product Category and Reporting Segment Our operations are managed through two reporting segments: Global Spine a… |
| LATTUS-SPINE-LLC |
LATTUS-SPINE-LLC |
62%
|
urement 1.9 9.2 Operating loss (7.3 ) (25.2 ) Net loss (10.6 ) (27.4 ) 22 Net Sales by Product Category and Reporting Segment Our operations are managed through two reporting segments: Global Spine a… |
| LEGION-INNOVATIONS-LLC |
LEGION-INNOVATIONS-LLC |
62%
|
n liability, see Note 12. Spinal Kinetics Contingent Consideration The Company recognized a contingent consideration obligation in connection with the acquisition of Spinal Kinetics in 2018. The fair… |
| OXFORD-FINANCE-LLC |
OXFORD-FINANCE-LLC |
62%
|
urement 1.9 9.2 Operating loss (7.3 ) (25.2 ) Net loss (10.6 ) (27.4 ) 22 Net Sales by Product Category and Reporting Segment Our operations are managed through two reporting segments: Global Spine a… |
| OXFORD-K2-HEALTHVENTURES-LLC |
OXFORD-K2-HEALTHVENTURES-LLC |
62%
|
urement 1.9 9.2 Operating loss (7.3 ) (25.2 ) Net loss (10.6 ) (27.4 ) 22 Net Sales by Product Category and Reporting Segment Our operations are managed through two reporting segments: Global Spine a… |
| SEASPINE-HOLDINGS-CORPORATION |
SEASPINE-HOLDINGS-CORPORATION |
62%
|
Item 16. Form 10-K Summary 82 Forward-Looking Statements This Annual Report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended ("… |
